Alignment Healthcare (ALHC) reported stronger-than-expected Q4 CY2025 revenue of $1.01 billion, marking a 44.4% year-on-year increase and beating analyst estimates by 1%. Despite this, the company’s Q1 CY2026 revenue guidance of $1.22 billion fell slightly short of expectations. Although the company posted a GAAP loss of $0.05 per share, this was still a 67.1% beat against consensus estimates, indicating some improvement in profitability.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Alignment Healthcare (NASDAQ:ALHC) Surprises With Q4 CY2025 Sales
Alignment Healthcare (ALHC) reported stronger-than-expected Q4 CY2025 revenue of $1.01 billion, marking a 44.4% year-on-year increase and beating analyst estimates by 1%. Despite this, the company’s Q1 CY2026 revenue guidance of $1.22 billion fell slightly short of expectations. Although the company posted a GAAP loss of $0.05 per share, this was still a 67.1% beat against consensus estimates, indicating some improvement in profitability.